This is a Phase 1/2, open-label, multi-center trial to evaluate the safety, immunogenicity, and preliminary efficacy of INO-5401 and INO-9012 in…
The purpose of this study is to find the biggest dose of GAP T cells that is safe, to see how long they last in the body, to learn what the side…
NCI MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple…
The purpose of this study is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a…
The purpose of this study is to find the largest effective and safe dose of GD2-CAR NKT cells to evaluate their effect on the tumor and how long they…
This randomized phase III trial studies Tokyo-172 strain BCG to see how well it works compared with TICE BCG solution in treating patients with…
This randomized phase II trial studies how well veliparib works with combination chemotherapy and radiation therapy in treating patients with rectal…
This is a national study looking at how safe and effective NanoPac therapy for patients with pancreatic cancer.
This is a national study looking at how safe and effective NanoPac therapy is for patients with a mucinous pancreatic cyst .
This is a research study using special immune system cells called tumor-associated antigen (TAA)-specific cytotoxic T lymphocytes, a new experimental…